glp-1 dosage charts Medications Explained: Chart, What's New, and What to Expect — Emerson Medical KLOW Peptide Dosage & Protocol

A new preclinical study at Northwestern Universitys Feinberg School of Medicine found that disrupting complex I function in mouse dopaminergic neurons led to progressive PD-related motor deficits, with loss of dopamine release in the substantia nigra being critical for motor deficits (40)

They are generating mice in which the protein SPHKAP can be specifically deleted from -cells, allowing them to examine how disrupting this signalling hub affects pancreatic function and GLP-1R signalling

Retatrutide dose compared to tirzepatide and semaglutide Comparison is inevitable

We have examined seven ways these treatments improve health outcomes across multiple body systems

doi: 10.1038/s41467-024-49655-6